Scarica l'app Stockscreener
101.26
6.34%
-6.86
Dopo l'orario di chiusura:
101.70
0.44
+0.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$108.12
Aprire:
$107.66
Volume 24 ore:
1.93M
Relative Volume:
2.16
Capitalizzazione di mercato:
$3.50B
Reddito:
$605.49M
Utile/perdita netta:
$190.29M
Rapporto P/E:
20.85
EPS:
4.8571
Flusso di cassa netto:
$133.59M
1 W Prestazione:
-7.02%
1M Prestazione:
+2.23%
6M Prestazione:
-21.93%
1 anno Prestazione:
+12.27%
Intervallo 1D:
$100.27
$107.86
Intervallo di 1 settimana:
$100.27
$119.14
Portata 52W:
$88.51
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
101.26 | 3.73B | 605.49M | 190.29M | 133.59M | 4.8571 |
ABT
Abbott Laboratories
|
93.86 | 161.26B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
321.43 | 126.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
81.90 | 106.46B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
58.45 | 89.10B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.28 | 48.12B | 6.30B | 1.07B | 1.34B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
TransMedics Group Inc (TMDX) Shares Fall 6.3% -- What GF Score o - GuruFocus
TransMedics Group (TMDX) to Release Quarterly Earnings on Tuesday - MarketBeat
TransMedics Unveils CHOPS As Trials Progress And Valuation Screens Undervalued - Yahoo Finance
TransMedics targets up to $605M 2025 revenue as international expansion accelerates - MSN
TransMedics Group Q4 2025 earnings preview - MSN
Universal Beteiligungs und Servicegesellschaft mbH Has $11.25 Million Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
Reasons to retain TransMedics stock in your portfolio for now - MSN
Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? - Insider Monkey
Is TransMedics’ New CHOPS Trial Control Device Reshaping The Investment Case For TransMedics Group (TMDX)? - simplywall.st
TransMedics: Revolutionizing The Organ Transplant Market While Trading At A Discount - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
(TMDX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TransMedics puts new organ-cooling device into heart, lung trial plans - Stock Titan
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Boston Scientific (BSX) - The Globe and Mail
A Look at TransMedics Group Inc (TMDX) After 5.3% Gain -- GF Val - GuruFocus
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026 - marketscreener.com
Organ Preservation Market to Reach USD 466.23 Million by 2033 - openPR.com
TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 33.77% Potential Upside in Medical Device Innovation - DirectorsTalk Interviews
TransMedics & Dexcom: Healthcare Stocks for Long-Term GrowthNews and Statistics - IndexBox
TransMedics Group (NASDAQ:TMDX) Stock Price Up 8.5%Here's What Happened - MarketBeat
Why TransMedics Group Stock Is Taking Off Today - TipRanks
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
TransMedics Group Inc (TMDX) Shares Fall 6.0% -- What GF Score o - GuruFocus
2 Healthcare Stocks That Could Outperform the Market Over the Next Decade - The Globe and Mail
TransMedics Group (NASDAQ:TMDX) Trading Down 5%Here's Why - MarketBeat
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Stryker (SYK) and Genmab (GMAB) - The Globe and Mail
Bears Pounce On Avis Budget, Lucid, MARA — Short Interest In These 10 Stocks Soars Above 40% - Benzinga
Does TransMedics Group's (TMDX) Cash Flow Turn and Fleet Expansion Reshape Its Capital Allocation Story? - Yahoo Finance
TransMedics (TMDX) down 20.3% since last earnings report: Can it rebound? - MSN
TransMedics Group, Inc. $TMDX Position Lifted by Baillie Gifford & Co. - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
How (TMDX) Movements Inform Risk Allocation Models - Stock Traders Daily
Tangible book value per share of TransMedics Group, Inc. – MUN:8T8 - TradingView — Track All Markets
TMDX SEC FilingsTransmedics Group 10-K, 10-Q, 8-K Forms - Stock Titan
RSI Check: Will TransMedics Group Inc benefit from government policy2026 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
A Look at TransMedics Group Inc (TMDX) After 4.4% Gain -- GF Value $177.87 vs Price $114.00 - GuruFocus
Nexstar Media Group Stock Jumps 5% Amid Sector-Wide Rally - AlphaStreet
[ARS] TransMedics Group, Inc. SEC Filing - Stock Titan
TransMedics (NASDAQ: TMDX) details 2025 surge, executive pay and proxy votes - Stock Titan
Q4 2025 Transmedics Group Inc Earnings Call Transcript - GuruFocus
Transmedics Group Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says - marketscreener.com
Oppenheimer reiterates TransMedics stock rating amid fuel costs By Investing.com - Investing.com India
Oppenheimer reiterates TransMedics stock rating amid fuel costs - Investing.com
TMDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Evercore ISI Group Initiates Coverage of TransMedics Group (TMDX) with Outperform Recommendation - MSN
Evercore ISI Group Lowers Price Target for TransMedics Group (TM - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):